USD 56.25
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 261.15 Million | 255.05 Million | 343.02 Million | 471.58 Million | 280.55 Million | 225.71 Million |
Net Income | 96.47 Million | 85.42 Million | 94.27 Million | 96.43 Million | 82.61 Million | 54.82 Million |
Depreciation & Amortization | 202.12 Million | 199.5 Million | -219.73 Million | -223.22 Million | -184.98 Million | 133.27 Million |
Deferred income taxes | -1.26 Million | 7.41 Million | -5.29 Million | -1.02 Million | -3.3 Million | -10.82 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -72.51 Million | -87.27 Million | -48.79 Million | 74.25 Million | -7.75 Million | -16.4 Million |
Other non-cash items | 491.38 Million | -391.35 Million | 71.64 Million | 69.56 Million | 25.91 Million | 383.35 Million |
Investing Cash Flow | -246.44 Million | -200.82 Million | -262.09 Million | -246.84 Million | -281.62 Million | -226.87 Million |
Investments in PPE | -178.91 Million | -188.39 Million | -260.77 Million | -243.85 Million | -245.76 Million | -195.93 Million |
Acquisitions | -37.17 Million | -3.54 Million | -3.37 Million | 11.84 Million | -32.43 Million | -32.03 Million |
Investment purchases | -32.5 Million | -16.81 Million | -2.94 Million | -14.82 Million | -3.42 Million | - |
Sales/Maturities of investments | 2.14 Million | 1.66 Million | 2.05 Million | -4.65 Million | -5.22 Million | 1.1 Million |
Other Investing Activities | -29.45 Million | 6.26 Million | 2.94 Million | 4.65 Million | 5.22 Million | -7000.00 |
Financing Cash Flow | 37.8 Million | -55.14 Million | -136.47 Million | 31.51 Million | 12.08 Million | -6.01 Million |
Debt repayment | -95.84 Million | -16.5 Million | -72.46 Million | -69.48 Million | -40.09 Million | -14.88 Million |
Dividends payments | -17.51 Million | -20.49 Million | -26.99 Million | -1.29 Million | -13.78 Million | -19.49 Million |
Common Stock Repurchased | -5.26 Million | -14.2 Million | -1.99 Million | -4.29 Million | -9.79 Million | - |
Common Stock Issuance | - | -30.6 Million | -4.33 Million | -30.8 Million | - | 1.11 Million |
Other Financing Activities | -6.91 Million | 33.04 Million | -30.68 Million | 137.38 Million | 77.44 Million | -2.52 Million |
Accounts receivables | -52.03 Million | -69.26 Million | -63.04 Million | -35.61 Million | -29.88 Million | 28.01 Million |
Accounts payables | 7.78 Million | 125.34 Million | 72.52 Million | -33.69 Million | 34.44 Million | -47.45 Million |
Inventory | -6.55 Million | -206.58 Million | -60.12 Million | -13.76 Million | -42.73 Million | -32.51 Million |
Other working capital | -21.7 Million | 63.23 Million | 1.85 Million | 157.33 Million | 30.42 Million | 35.55 Million |
Cash at beginning of period | 548.61 Million | 489.31 Million | 524.6 Million | 329.99 Million | 318.76 Million | 362.11 Million |
Cash at end of period | 590.98 Million | 496.9 Million | 489.31 Million | 524.6 Million | 329.99 Million | 471.93 Million |
Capital Expenditure | -178.91 Million | -188.39 Million | -260.77 Million | -243.85 Million | -245.76 Million | -195.93 Million |
Effect of forex changes on cash | -16.33 Million | 8.5 Million | 13.57 Million | -14.83 Million | 1.42 Million | 3.51 Million |
Net cash flow / Change in cash | 42.36 Million | 7.58 Million | -35.29 Million | 194.6 Million | 11.23 Million | 109.82 Million |
Free Cash Flow | 82.24 Million | 66.65 Million | 82.25 Million | 227.72 Million | 34.79 Million | 29.78 Million |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 62.03 Million | 96.47 Million | 49.88 Million | 55.93 Million | 85.42 Million | -3.49 Million |
Depreciation & Amortization | 111.42 Million | 202.12 Million | 119.92 Million | 103.59 Million | 199.5 Million | 114.05 Million |
Deferred income taxes | -3.85 Million | -1.26 Million | -4.55 Million | 3.12 Million | 7.41 Million | 4.6 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -74.32 Million | -72.51 Million | 130.93 Million | -208.48 Million | -87.27 Million | 117.42 Million |
Other non-cash items | 45.96 Million | 491.38 Million | 251.16 Million | 233.98 Million | -391.35 Million | 283 Million |
Investing Cash Flow | -160.25 Million | -246.44 Million | -110.2 Million | -159.9 Million | -200.82 Million | -124.34 Million |
Investments in PPE | -100.97 Million | -178.91 Million | -119.95 Million | -76.6 Million | -188.39 Million | -120.36 Million |
Acquisitions | 4.18 Million | -37.17 Million | -8.24 Million | -32.39 Million | -3.54 Million | 7.62 Million |
Investment purchases | -63.47 Million | -32.5 Million | 17.08 Million | -52.34 Million | -16.81 Million | -13.38 Million |
Sales/Maturities of investments | 23.56 Thousand | 2.14 Million | 911.68 Thousand | 1.43 Million | 1.66 Million | 1.78 Million |
Other Investing Activities | - | -29.45 Million | -25.25 Million | -1.00 | 6.26 Million | 1.00 |
Financing Cash Flow | 186.18 Million | 37.8 Million | -147.47 Million | 186.97 Million | -55.14 Million | 122.27 Million |
Debt repayment | -225.37 Million | -95.84 Million | -136.16 Million | -239.1 Million | -16.5 Million | -145.3 Million |
Dividends payments | -20.04 Million | -17.51 Million | - | -19.09 Million | -20.49 Million | -21.93 Million |
Common Stock Repurchased | -344.9 Thousand | -5.26 Million | -5.39 Million | -414.48 Thousand | -14.2 Million | -1.58 Million |
Common Stock Issuance | - | - | -15.81 Million | -15.29 Million | -30.6 Million | -3.93 Million |
Other Financing Activities | -18.79 Million | -6.91 Million | 9.89 Million | -17.32 Million | 33.04 Million | 19.93 Million |
Accounts receivables | - | -52.03 Million | - | - | -69.26 Million | - |
Accounts payables | - | 7.78 Million | - | - | 125.34 Million | - |
Inventory | - | -6.55 Million | - | - | -206.58 Million | - |
Other working capital | -74.32 Million | -21.7 Million | 130.93 Million | - | 63.23 Million | - |
Cash at beginning of period | 652.29 Million | 548.61 Million | 665.82 Million | 587.15 Million | 489.31 Million | 444.01 Million |
Cash at end of period | 816.46 Million | 590.98 Million | 652.29 Million | 665.82 Million | 496.9 Million | 587.15 Million |
Capital Expenditure | -100.97 Million | -178.91 Million | -119.95 Million | -76.6 Million | -188.39 Million | -120.36 Million |
Effect of forex changes on cash | - | -16.33 Million | -63.35 Million | -0.32 | 8.5 Million | -142.29 Million |
Net cash flow / Change in cash | 164.17 Million | 42.36 Million | -13.52 Million | 78.66 Million | 7.58 Million | 143.13 Million |
Free Cash Flow | 40.26 Million | 82.24 Million | 187.54 Million | -95.63 Million | 66.65 Million | 167.13 Million |
002630
AKVA
PNPNF
CRJ
600754
NEOGEN